Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: Survey from a single institution

Massimo Magagnoli, Luca Castagna, Monica Balzarotti, Barbara Sarina, Inna Timofeeva, Alexia Bertuzzi, Silvana Compasso, Andrea Nozza, Licia Siracusano, Armando Santoro

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: Survey from a single institution'. Together they form a unique fingerprint.

Medicine & Life Sciences